erbium,(Z)-1,1,1,5,5,5-hexafluoro-4-hydroxypent-3-en-2-one,hydrate

Modify Date: 2024-01-07 00:33:21

erbium,(Z)-1,1,1,5,5,5-hexafluoro-4-hydroxypent-3-en-2-one,hydrate Structure
erbium,(Z)-1,1,1,5,5,5-hexafluoro-4-hydroxypent-3-en-2-one,hydrate structure
Common Name erbium,(Z)-1,1,1,5,5,5-hexafluoro-4-hydroxypent-3-en-2-one,hydrate
CAS Number 18923-92-7 Molecular Weight 806.42600
Density N/A Boiling Point N/A
Molecular Formula C15H5ErF18O7 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name erbium,(Z)-1,1,1,5,5,5-hexafluoro-4-hydroxypent-3-en-2-one,hydrate

 Chemical & Physical Properties

Molecular Formula C15H5ErF18O7
Molecular Weight 806.42600
Exact Mass 804.90500
PSA 88.13000
LogP 6.07040

 MSDS


Section 1: Product Identification
Chemical Name:Erbium (III) hexafluoroacetylacetonate hydrate (99.9%-Er) (REO)
CAS Registry Number:18923-92-7
Formula:C15H3ErF18O6
EINECS Number:none
Chemical Family:metal fluorobeta-diketonate complexes
Synonym:Tris(1,1,1,6,6,6-hexafluoro-2,4-pentanedionato)erbium (III) hydrate

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title compound18923-92-7100%no datano data

Section 3: Hazards Identification
Emergency Overview:Irritating to skin, eyes and respiratory tract.
Primary Routes of Exposure:Ingestion, inhalation
Eye Contact:Causes slight to mild irritation of the eyes.
Skin Contact:Causes slight to mild irritation of the skin.
Inhalation:Irritating to the respiratory tract, skin and eyes.
Ingestion:No information is available on the physiological effects of ingestion.
Acute Health Affects:Irritating to skin, eyes and respiratory tract.
Product contains fluorine which under certain conditions of use, decomposition, or metabolism, may generate
Chronic Health Affects:fluoride ion, causing, nausea, vomiting, labored breathing, hypocalcaemia, deterioration of bone and tooth
structure, kidney and liver damage.
NTP:No
IARC:No
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:none
Autoignition Temperature:none
Explosion Limits:none
Extinguishing Medium:carbon dioxide, dry powder or foam
Fire fighters should be equipped with a NIOSH approved positive pressure self-contained breathing apparatus
Special Fire Fighting Procedures:
and full protective clothing.
Hazardous Combustion andIf involved in a fire this material may emit irritating fumes and toxic carbonyl fluoride and hydrogen fluoride.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Small spills can be mixed with vermiculite, sodium carbonate or other suitable noncombustible adsorbent and
Spill and Leak Procedures:
swept up.

SECTION 7: Handling and Storage
Handling and Storage:Store in a tightly sealed container. Handle in a ventilated area.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear protective clothing and gloves. Consult with glove manufacturer to determine the proper type of glove.
Ventilation:Handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation:Handle the material in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:pink xtl
Molecular Weight:788.45
Melting Point:no data
Boiling Point:no data
Vapor Pressure:no data
Specific Gravity:no data
Odor:none
Solubility in Water:insoluble

SECTION 10: Stability and Reactivity
Stability:air and moisture stable
Hazardous Polymerization:no hazardous polymerization
Conditions to Avoid:none
Incompatibility:oxidizing agents and active metals
Decomposition Products:carbon dioxide, carbon monoxide, organic fumes, carbonyl fluoride, hydrogen fluoride and erbium salts.

SECTION 11: Toxicological Information
RTECS Data:No information available in the RTECS files.
Carcinogenic Effects:no data
Mutagenic Effects:no data
Tetratogenic Effects:no data

SECTION 12: Ecological Information
Ecological Information:No information available

SECTION 13: Disposal Considerations
Disposal:Dispose of according to federal, state, and local regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Not listed in the TSCA inventory.
SARA (Title 313):Title compound not listed.
Second Ingredient:none


SECTION 16 - ADDITIONAL INFORMATION
N/A
Top Suppliers:I want be here

No recommended suppliers.

Hot Compounds More...
Dichloromethane
CAS#:75-09-2
Polyacrylic acid
CAS#:9003-01-4
sodium carbonate
CAS#:497-19-8
Silicon dioxide
CAS#:7631-86-9
Triethanolamine
CAS#:102-71-6
Demeton
CAS#:126-75-0
Water
CAS#:7732-18-5
4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9
Diclofenac sodium
CAS#:15307-79-6
Budesonide
CAS#:51372-29-3